Picture of Monte Rosa Therapeutics logo

GLUE — Monte Rosa Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapNeutral

Brief: Monte Rosa Therapeutics Announces Pricing Of $300 Million Underwritten Public Offering At $24.00 Per Share

Jan 8 (Reuters) - Monte Rosa Therapeutics Inc GLUE.O:

MONTE ROSA THERAPEUTICS ANNOUNCES PRICING OF $300 MILLION UNDERWRITTEN PUBLIC OFFERING

MONTE ROSA THERAPEUTICS INC - PRICES PUBLIC OFFERING AT $24.00 PER SHARE

Source text: ID:nGNX4K4Lld

Further company coverage: GLUE.O

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Monte Rosa Therapeutics

See all news